Related content

Association between percutaneous coronary intervention and long-term C-reactive protein levels in patients with acute coronary syndromes

By Ray Kausik   Nazer Babak   Cairns Richard   Michael Gibson C.   Cannon Christopher  

Journal of Thrombosis and Thrombolysis, Vol. 30, Iss. 1, 2010-07 ,pp. : 10-13

Springer Publishing Company

Access to resources Recommend Favorite

The levels of C‐reactive protein in women treated by IVF

By Almagor Miriam  

Human Reproduction, Vol. 19, Iss. 1, 2004-01 ,pp. : 104-106

Oxford University Press

Access to resources Recommend Favorite

C-reactive protein and coronary events following percutaneous coronary angioplasty

By de Winter R.J.   Koch K.T.   van Straalen J.P.  

ACC Current Journal Review, Vol. 12, Iss. 6, 2003-11 ,pp. : 49-50

Elsevier

Access to resources Recommend Favorite

The effects of rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, on markers of endothelial cell activation, C-reactive protein, and fibrinogen levels in non-diabetic coronary artery disease patients

By Sidhu J.S.   Cowan D.   Kaski J.-C.  

Journal of the American College of Cardiology, Vol. 42, Iss. 10, 2003-11 ,pp. : 1757-1763

Elsevier

Access to resources Recommend Favorite

Changes in serum interleukin-6 and high-sensitivity C-reactive protein levels in patients with acute coronary syndrome and their responses to simvastatin

By Luo Yumei   Jiang Deqian   Wen Dan   Yang Jianxin   Li Liying  

Heart and Vessels, Vol. 19, Iss. 6, 2004-11 ,pp. : 257-262

Springer Publishing Company

Access to resources Recommend Favorite